rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Maria Dobek

Vice President, Accounting

Company insider

Files Form 4 as: Vice President, Accounting, Janux Therapeutics.

In numbers

Trades disclosed
10
Buys
0
Sells
2
Bought
$0
Sold
$98K
Companies
1
Companies where not an officer
0
First trade
2 Jan 2025
Last trade
11 May 2026
Last filed
13 May 2026

Companies traded

Where they are an officer
JANX Janux TherapeuticsOfficer · Biotechnology · last 11 May 20260 buys · 2 sells

Activity over time

1 Dec 2025 – 1 Oct 2026
10Dec 25Mar 26May 26Aug 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
11 May 2026filed 13 May 2026JANX Janux TherapeuticsBiotechnologySEC FORM 4 Sold$29K2,038 at $14.17filing
11 May 2026filed 13 May 2026JANX Janux TherapeuticsBiotechnologySEC FORM 4 Sold$29K2,038 at $14.17filing
2 Jan 2026filed 2 Jan 2026JANX Janux TherapeuticsBiotechnologySEC FORM 4 Sold$20K1,462 at $13.73filing
2 Jan 2026filed 2 Jan 2026JANX Janux TherapeuticsBiotechnologySEC FORM 4 Code A—18,935 at $0.00filing
2 Jan 2026filed 2 Jan 2026JANX Janux Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—42,600 at $0.00filing
2 Jan 2026filed 2 Jan 2026JANX Janux Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—42,600 at $0.00filing
2 Jan 2026filed 2 Jan 2026JANX Janux TherapeuticsBiotechnologySEC FORM 4 Sold$20K1,462 at $13.73filing
2 Jan 2026filed 2 Jan 2026JANX Janux TherapeuticsBiotechnologySEC FORM 4 Code A—18,935 at $0.00filing
2 Jan 2025filed 3 Jan 2025JANX Janux Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—31,500 at $0.00filing
2 Jan 2025filed 3 Jan 2025JANX Janux TherapeuticsBiotechnologySEC FORM 4 Code A—14,000 at $0.00filing

News

Reviewing Janux Therapeutics (NASDAQ:JANX) & Roivant Sciences (NASDAQ:ROIV)JANX · themarketsdaily.com · 11 Oct 2026

0 headlines in the last 90 days name Maria Dobek; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

David Alan CampbellPresident and CEO · President and CEO at Janux Therapeutics, filing Form 4 there in the last year
Vickie L. CappsDirector · Director at Janux Therapeutics, filing Form 4 there in the last year
Ronald W. BarrettDirector · Director at Janux Therapeutics, filing Form 4 there in the last year
RA CAPITAL MANAGEMENT, L.P.Director and 10% owner · Director and 10% owner at Janux Therapeutics, filing Form 4 there in the last year
Winston KungDirector · Director at Janux Therapeutics, filing Form 4 there in the last year